Based on this knowledge, molecules involved in mTOR signaling could be explored as future biomarkers for the prediction and prevention of endometriosis and ovarian cancer development, while further assessment of the therapeutic potential of mTOR pathway inhibitors in both endometriosis and EAOC would be necessary. This evidence concerns the gene MTOR and ovarian cancer.